10.1016/j.foodchem.2014.07.106 54 Krajka-KuniakV.Baer-DubowskaW
Key evidence considerations include: Gastric emptying effects vary by medication: tirzepatide has more pronounced effects than semaglutide or liraglutide Gastrointestinal side effects (nausea, vomiting, diarrhoea) may independently affect oral contraceptive absorption Individual variation exists in how people respond to these medications Weight loss itself can alter hormone levels and potentially affect fertility Product information for these medications notes that slowed gastric emptying may impact the absorption of oral medicines

[12] Monitoring and patient safety advice: Patients should be monitored regularly during treatment, with assessment of: Weight and BMI Metabolic parameters (fasting glucose, HbA1c, lipid profile) Menstrual cycle patterns Symptoms of adverse effects When to contact your GP: Patients should seek medical advice if they experience severe or persistent abdominal pain, signs of pancreatitis, symptoms of gallbladder disease, unexplained neck lumps, significant mood changes, or if they suspect pregnancy
This aligns with what we know about microbiome-based interventions
Retrieved 14 May 2022, from A Phase II, Randomized, Open Label Pilot Study to Evaluate the Efficacy and Safety of Two Dosage Regimens of Subcutaneous Bioresorbable Afamelanotide Implants in Patients with Mild to Moderate Acne Vulgaris